Detalhe da pesquisa
1.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 16, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166764
2.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703239
3.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734870
4.
Impact of coronaphobia on treatment and follow-up compliance of cancer patients.
Future Oncol
; 17(20): 2621-2629, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880932
5.
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.
Future Oncol
; 17(31): 4157-4169, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323116
6.
The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment.
Colorectal Dis
; 23(1): 206-212, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002301
7.
Assessment of abuse and related factors in older patients with cancer.
Support Care Cancer
; 29(12): 7957-7964, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213643
8.
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 114, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262962
9.
Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy.
Asia Pac J Clin Oncol
; 19(1): 104-112, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538045
10.
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.
J Chemother
; 35(1): 19-28, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174772
11.
Prognostic significance of mucinous histology in leftsided metastatic colorectal cancers with wildtype RAS and evaluation of backbone chemotherapy regimens.
Oncol Lett
; 25(5): 208, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37123028
12.
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
J Cancer Res Clin Oncol
; 149(2): 865-875, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381885
13.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
J Cancer Res Clin Oncol
; 149(8): 4141-4148, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048274
14.
Major and minor salivary gland cancers: A multicenter retrospective study.
Head Neck
; 45(7): 1643-1653, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084179
15.
A new biomarker for lung metastasis in non-seminomatous testicular cancer: De Ritis Ratio.
Aktuelle Urol
; 53(6): 540-544, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302549
16.
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
Expert Rev Anticancer Ther
; 22(7): 773-780, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543015
17.
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study.
Oncol Res Treat
; 45(5): 254-261, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034017
18.
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.
J Chemother
; 34(7): 465-471, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037592
19.
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.
Tumori
; 108(1): 19-25, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365852
20.
Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.
Curr Med Res Opin
; 38(10): 1751-1758, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916475